Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562

ABSTRACT: Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562

PROVIDER: PRJNA470944 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7146390.fastq.gz	Fastqsanger.gz
	SRR7146400.fastq.gz	Fastqsanger.gz
	SRR7146391.fastq.gz	Fastqsanger.gz
	SRR7146401.fastq.gz	Fastqsanger.gz
	SRR7146392.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562

Project description:RNA-sequencing on human leukemia cell lines MOLM13 (AML, MLL-AF9+) and K562 (CML-BC, BCR-ABL+) after Ro 08-2750 treatment (20 uM, 4hours)

2019-05-09 | GSE114320 | GEO

MOLM13 TP53 gene-edited cell lines

Project description:MOLM13 TP53 gene-edited cell lines Raw sequence reads

| PRJNA1133701 | ENA

RNA-seq identifies differential expressed genes upon YTHDC1 knockdown in MOLM13 human acute myeloid leukemia cells

Project description:The goal of this study is to identify differential expressed genes upon YTHDC1 depletion in MOLM13 cells(AML).

2021-05-24 | GSE168565 | GEO

landfill leachate RO

Project description:landfill leachate RO Raw sequence reads

| PRJNA887845 | ENA

Gene expression data of ODH-08-treated Western diet-fed murine liver

Project description:Hepatic fibrosis is a dynamic process characterized by the net accumulation of extracellular matrix resulting from chronic liver injury such as nonalcoholic steatohepatitis. During the pathogenesis of hepatic fibrosis, activation of hepatic stellate cells (HSCs) causes transdifferentiation of quiescent cells into proliferative and fibrogenic myofibroblasts. In the present study, we developed a novel RORα-selective ligand, ODH-08, based on the modification of JC1-40, a previously reported N-methylthiourea analog. Administration of ODH-08 to Western diet (WD)-fed mice improved the signs of hepatic fibrosis: decreased hepatic collagen deposition and suppression of the expression of fibrogenic markers. ODH-08 inhibits the TGF1-induced fibrogenic activation of HSCs through suppression of the TGFβ1–SMAD signaling pathway, which represents a novel mechanism for the antifibrogenic effect of RORα. Thus, ODH-08 appears to be a promising antifibrotic agent to treat hepatic fibrosis. We performed a microarray analysis in the liver tissue of ODH-08-treated WD-fed mice to anlyse differentially expressed genes under ODH-08 administration. The control group was vehicle-treated WD-fed mice.

2024-03-01 | GSE250531 | GEO

Small molecule inhibition of multiple RNA binding proteins underlies Musashi-2 independent phenotypes

Project description:RNA binding proteins (RBPs) are key regulators of normal and pathological gene expression. Small molecules targeting RBP-RNA interactions are a rapidly emerging class of therapeutics. Ro-08-2750 (Ro) was previously identified as a competitive inhibitor of Musashi-RNA interactions. Here we show Ro potently inhibits steroidogenesis and viability independent of Musashi-2 in multiple cell lines. We identified Ro-interacting proteins using an unbiased proteome-wide approach. Other RBPs were a prominent class of Ro-interacting proteins and leveraging large-scale ENCODE data we found a subset of these phenocopy Ro inhibition. We provide a general framework for validating the specificity and identifying targets of RBP inhibitors in a cellular context.

2022-09-14 | GSE213218 | GEO

miCLIP, RNA-Seq, and Ribo-Seq in MOLM13 cells

Project description:We studied the following conditions: m6A RNA methylation in MOLM13 AML cells; METTL3 deficiency on gene expression and translational efficiency

2017-09-18 | GSE98623 | GEO

ChIP-seq from K562 (ENCSR830KKO)

Project description:Reverse Crosslink Control ChIP-seq on human K562 (fragmentation date 04-08-13) For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2017-03-12 | GSE96404 | GEO

ChIP-seq from K562 (ENCSR571CEX)

2017-03-12 | GSE96245 | GEO

ChIP-seq from K562 (ENCSR896JFO)

2017-03-12 | GSE96453 | GEO